April 2017 FDA Recall Drug by Teva Pharmaceuticals Usa
D-0705-2017 - Microbial Contamination of Non-Sterile Products

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on April 24, 2017 for the product Drug. The FDA reported the reason for recall as microbial contamination of non-sterile products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0705-2017

Reason for Recall
Microbial Contamination of Non-Sterile Products
Initiated
04-24-2017
Reported
05-17-2017
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA
Clozapine Tablets USP, 25 mg, 100-count bottle (NDC 0093-4359-01), 500- count bottle (NDC 0093-4359-05), 100 Unit Dose Blisters per carton (NDC 0093-4359-93), Individual Blister Pack (NDC 0093-4359-19), Rx Only, Manufactured By: Teva Pharmaceutical Industries Ltd., Jerusalem, 9777600, Israel

Batch or Lot Expiration Information

Lot# 100 (NDC 0093-4359-01) and 500 count bottles (NDC 0093-4359-05)-
Lot# 07C160; Exp. 03/18 100 Unit Dose Blisters/Carton (NDC 0093-4359-93) and Individual Blister Pack (NDC 0093-4359-19) -
Lot# 07C160A; Exp. 03/18